Gujarat, India

Mukul Hariprasad Sharma

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Cadila Healthcare Limited. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mukul Hariprasad Sharma. Retrieved from https://idiyas.com/inventor/mukul-hariprasad-sharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 25.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mukul Hariprasad Sharma: Innovator in Pharmaceutical Patents

Introduction: Mukul Hariprasad Sharma is an accomplished inventor based in Gujarat, India, recognized for his significant contributions to the field of pharmaceuticals. With a total of four patents to his name, Sharma has made a mark in the development of medications that address critical health concerns.

Latest Patents: Among his most notable inventions are the polymorphic forms of ivabradine hydrochloride. He has disclosed stable crystalline Form II and stable crystalline Form III of ivabradine hydrochloride, along with the processes for their preparation. These innovations have potential implications in improving the efficacy and stability of the medication, showcasing Sharma's dedication to advancing pharmaceutical science.

Career Highlights: Mukul Hariprasad Sharma currently works at Cadila Healthcare Limited, a prominent player in the healthcare industry. His role involves not only inventing but also improving existing pharmaceuticals, ensuring that safe and effective medicines reach the market.

Collaborations: Throughout his career, Sharma has collaborated with esteemed colleagues such as Shriprakash Dhar Dwivedi and Ashok Prasad. These partnerships have fostered a rich environment for innovation and shared knowledge, vital for progressing in complex pharmaceutical research.

Conclusion: In summary, Mukul Hariprasad Sharma stands out as a noteworthy inventor in the pharmaceutical sector. His work, especially in developing polymorphic forms of ivabradine hydrochloride, reflects his commitment to enhancing medicine and healthcare outcomes. As he continues to innovate, the impact of his contributions will likely resonate within the industry for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…